Akut lebensbedrohliche Herzrhythmusstörungen

Herzrhythmusstörungen sind ein häufiges Phänomen und können in der Akutsituation eine Herausforderung für die behandelnden Ärzte darstellen. Der Beitrag stellt wichtige bradykarde und tachykarde Herzrhythmusstörungen vor und gibt praktische Hinweise zur Diagnostik und Therapie.

Schlüsselwörter

Rhythmusstörung - Herzfrequenz - Bradykardie - Tachykardie - EKG

• Literatur

• 1 Perkins GD, Graesner J-T, Semeraro F. et al. European Resuscitation Council Guidelines 2021: executive summary. Resuscitation 2021; 161: 1-60
• 2 Brugada J, Katritsis DG, Arbelo E. et al. 2019 ESC Guidelines for the management of patients with supraventricular tachycardia. The Task Force for the management of patients with supraventricular tachycardia of the European Society of Cardiology (ESC). Eur Heart J 2020; 41: 655-720
• 3 Eitel C, Arya A, Hindricks G. Ausflusstrakttachykardie. In: Lehnert H, Märker-Hermann E, Marx N, Meyhöfer SM. DGIM Innere Medizin. Berlin, Heidelberg: Springer; 2024: 1-7
• 4 Zeppenfeld K, Tfelt-Hansen J, de Riva M. et al. 2022 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death. Eur Heart J 2022; 43: 3997-4126
• 5 Könemann H, Dagres N, Merino JL. et al. Spotlight on the 2022 ESC guideline management of ventricular arrhythmias and prevention of sudden cardiac death: 10 novel key aspects. Europace 2023; 25: euad091
• 6 Ortiz M, Martín A, Arribas F. et al. Randomized comparison of intravenous procainamide vs. intravenous amiodarone for the acute treatment of tolerated wide QRS tachycardia: the PROCAMIO study. Eur Heart J 2017; 38: 1329-1335
• 7 Larrey D, Pessayre D, Duhamel G. et al. Prolonged cholestasis after ajmaline-induced acute hepatitis. J Hepatol 1986; 2: 81-87
• 8 Korthals D, Eckardt L. Die neue ESC-Leitlinie (ESC: European Society of Cardiology) zum Management von Kardiomyopathien: Schlüsselbotschaft für kardiale Elektrophysiologen. Herzschr Elektrophys 2023; 34: 311-323
• 9 Kusumoto FM, Schoenfeld MH, Barrett C. et al. 2018 ACC/AHA/HRS Guideline on the evaluation and management of patients with bradycardia and cardiac conduction delay: a report of the American College of Cardiology/American Heart Association Task Force on clinical practice guidelines and the Heart Rhythm Society. Circulation 2019; 140: e382-e482
• 10 Hasan F, Bogossian H, Lemke B. Akute Bradykardien. Herzschrittmacherther Elektrophysiol 2020; 31: 3-9
• 11 Byrne RA, Rossello X, Coughlan JJ. et al. 2023 ESC Guidelines for the management of acute coronary syndromes. Eur Heart J 2023; 44: 3720-3826
• 12 Güler S, Könemann H, Wolfes J. et al. Lidocaine as an anti-arrhythmic drug: are there any indications left?. Clin Transl Sci 2023; 16: 2429-2437
• 13 van der Werf C, Kannankeril PJ, Sacher F. et al. Flecainide therapy reduces exercise-induced ventricular arrhythmias in patients with catecholaminergic polymorphic ventricular tachycardia. J Am Coll Cardiol 2011; 57: 2244-2254
• 14 Wang G, Zhao N, Zhong S. et al. Safety and efficacy of flecainide for patients with catecholaminergic polymorphic ventricular tachycardia: A systematic review and meta-analysis. Medicine (Baltimore) 2019; 98: e16961
• 15 Viskin S, Chorin E, Viskin D. et al. Polymorphic Ventricular Tachycardia: Terminology, Mechanism, Diagnosis, and Emergency Therapy. Circulation 2021; 144: 823-839
• 16 Frommeyer G, Eckardt L. Drug-induced proarrhythmia: risk factors and electrophysiological mechanisms. Nat Rev Cardiol 2016; 13: 36-47
• 17 Milberg P, Hilker E, Ramtin S. et al. Proarrhythmia as a class effect of quinolones: increased dispersion of repolarization and triangulation of action potential predict torsades de pointes. J Cardiovasc Electrophysiol 2007; 18: 647-654
• 18 Deneke T, Nentwich K, Ene E. et al. Akutversorgung bei ventrikulärer Tachykardie. Herzschrittmacherther Elektrophysiol 2020; 31: 26-32
• 19 Kudenchuk PJ, Leroux BG, Daya M. et al. Antiarrhythmic drugs for nonshockable-turned-shockable out-of-hospital cardiac arrest: the ALPS study (amiodarone, lidocaine, or placebo). Circulation 2017; 136: 2119-2131
• 20 Lenarczyk R, Zeppenfeld K, Tfelt-Hansen J. et al. Management of patients with an electrical storm or clustered ventricular arrhythmias: a clinical consensus statement of the European Heart Rhythm Association of the ESC-endorsed by the Asia-Pacific Heart Rhythm Society, Heart Rhythm Society, and Latin-American Heart Rhythm Society. Europace 2024; 26: euae049
• 21 Alhourani N, Wolfes J, Könemann H. et al. Relevance of mexiletine in the era of evolving antiarrhythmic therapy of ventricular arrhythmias. Clin Res Cardiol 2024; 113: 791-800
• 22 Eckardt L, Veltmann C. 30 Jahre Brugada-Syndrom – eine kritische Bewertung und Diskussion offener Fragen. Herzschr Elektrophys 2024; 35: 9-18
• 23 Chatzidou S, Kontogiannis C, Tsilimigras DI. et al. Propranolol Versus Metoprolol for Treatment of Electrical Storm in Patients With Implantable Cardioverter-Defibrillator. J Am Coll Cardiol 2018; 71: 1897-1906
• 24 Connolly SJ, Dorian P, Roberts RS. et al. Comparison of beta-blockers, amiodarone plus beta-blockers, or sotalol for prevention of shocks from implantable cardioverter defibrillators: the OPTIC Study: a randomized trial. JAMA 2006; 295: 165-171
• 25 Vogler J, Breithardt G, Eckardt L. Bradyarrhythmias and conduction blocks. Rev Esp Cardiol (Engl Ed) 2012; 65: 656-667
• 26 Moccetti F, Yadava M, Latifi Y. et al. Simplified integrated clinical and electrocardiographic algorithm for differentiation of wide QRS complex tachycardia: the Basel algorithm. JACC Clin Electrophysiol 2022; 8: 831-839
• 27 Milberg P, Reinsch N, Osada N. et al. Verapamil prevents torsade de pointes by reduction of transmural dispersion of repolarization and suppression of early afterdepolarizations in an intact heart model of LQT3. Basic Res Cardiol 2005; 100: 365-371